819 related articles for article (PubMed ID: 17515707)
1. Zolpidem extended-release: a single insomnia treatment option for sleep induction and sleep maintenance symptoms.
Barkin RL
Am J Ther; 2007; 14(3):299-305. PubMed ID: 17515707
[TBL] [Abstract][Full Text] [Related]
2. Treatment options for insomnia--pharmacodynamics of zolpidem extended-release to benefit next-day performance.
Bogan RK
Postgrad Med; 2008 Sep; 120(3):161-71. PubMed ID: 18824834
[TBL] [Abstract][Full Text] [Related]
3. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
[TBL] [Abstract][Full Text] [Related]
4. Insomnia: zolpidem extended-release for the treatment of sleep induction and sleep maintenance symptoms.
Doghramji PP
MedGenMed; 2007 Jan; 9(1):11. PubMed ID: 17435620
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia.
Roth T; Soubrane C; Titeux L; Walsh JK;
Sleep Med; 2006 Aug; 7(5):397-406. PubMed ID: 16815744
[TBL] [Abstract][Full Text] [Related]
7. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
Jhaveri M; Seal B; Pollack M; Wertz D
Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
[TBL] [Abstract][Full Text] [Related]
8. Eszopiclone, a nonbenzodiazepine sedative-hypnotic agent for the treatment of transient and chronic insomnia.
Najib J
Clin Ther; 2006 Apr; 28(4):491-516. PubMed ID: 16750462
[TBL] [Abstract][Full Text] [Related]
9. Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week, randomized, multicenter, double-blind, placebo-controlled study.
Dorsey CM; Lee KA; Scharf MB
Clin Ther; 2004 Oct; 26(10):1578-86. PubMed ID: 15598474
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
Scharf MB; Roth T; Vogel GW; Walsh JK
J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
[TBL] [Abstract][Full Text] [Related]
12. Sleeping through the night: are extended-release formulations the answer?
Calamaro C
J Am Acad Nurse Pract; 2008 Feb; 20(2):69-75. PubMed ID: 18271761
[TBL] [Abstract][Full Text] [Related]
13. Conventional and power spectrum analysis of the effects of zolpidem on sleep EEG in patients with chronic primary insomnia.
Monti JM; Alvariño F; Monti D
Sleep; 2000 Dec; 23(8):1075-84. PubMed ID: 11145322
[TBL] [Abstract][Full Text] [Related]
14. Zolpidem: a nonbenzodiazepine hypnotic for treatment of insomnia.
Hoehns JD; Perry PJ
Clin Pharm; 1993 Nov; 12(11):814-28. PubMed ID: 8275648
[TBL] [Abstract][Full Text] [Related]
15. Zolpidem's use for insomnia.
Monti JM; Spence DW; Buttoo K; Pandi-Perumal SR
Asian J Psychiatr; 2017 Feb; 25():79-90. PubMed ID: 28262178
[TBL] [Abstract][Full Text] [Related]
16. Sublingual zolpidem is more effective than oral zolpidem in initiating early onset of sleep in the post-nap model of transient insomnia: a polysomnographic study.
Staner L; Eriksson M; Cornette F; Santoro F; Muscat N; Luthinger R; Roth T
Sleep Med; 2009 Jun; 10(6):616-20. PubMed ID: 18996742
[TBL] [Abstract][Full Text] [Related]
17. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
18. Effects of zolpidem on cyclic alternating pattern, an objective marker of sleep instability, in Japanese patients with psychophysiological insomnia: a randomized crossover comparative study with placebo.
Ozone M; Yagi T; Itoh H; Tamura Y; Inoue Y; Uchimura N; Sasaki M; Shimizu T; Terzano MG; Parrino L
Pharmacopsychiatry; 2008 May; 41(3):106-14. PubMed ID: 18484552
[TBL] [Abstract][Full Text] [Related]
19. Dynamics and kinetics of a modified-release formulation of zolpidem: comparison with immediate-release standard zolpidem and placebo.
Greenblatt DJ; Legangneux E; Harmatz JS; Weinling E; Freeman J; Rice K; Zammit GK
J Clin Pharmacol; 2006 Dec; 46(12):1469-80. PubMed ID: 17101746
[TBL] [Abstract][Full Text] [Related]
20. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
Staner L; Danjou P; Luthringer R
Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
